The report provides a detailed analysis essential for establishing an oxprenolol production plant. It encompasses all critical aspects necessary for oxprenolol production, including the cost of oxprenolol production, oxprenolol plant cost, oxprenolol production costs, and the overall oxprenolol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an oxprenolol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Oxprenolol is a non-selective beta-blocker with intrinsic sympathomimetic activity. It is used in the applications of cardiovascular medicine and anxiety management. It is used in the treatment of hypertension, effectively lowering blood pressure by reducing heart rate, cardiac output, and peripheral vascular resistance.
It leads to competitive blockade of beta-1 and beta-2 adrenergic receptors, making it suitable for long-term monotherapy or combination therapy with diuretics. It is used in angina pectoris and decreases myocardial oxygen demand by slowing the heart rate and reducing contractility. It is also used in managing cardiac arrhythmias, like ventricular ectopic beats, supraventricular tachycardia, and atrial fibrillation, especially in patients recovering from myocardial infarction.
The market for oxprenolol is driven by its usage as a generic beta-blocker. Its expansion in developing regions for hypertension and arrhythmia treatments contributes to its demand. The research into novel indications like S-oxprenolol for amyotrophic lateral sclerosis cachexia in preclinical stages boosts its demand. Its regulatory availability, leading to supply chain reliance on API manufacturers in China and India, impacts industrial oxprenolol procurement.
The price instability from low-volume production, competition from newer beta-blockers like metoprolol and bisoprolol, and raw material costs for synthesis impact its sourcing. The strict quality controls, market challenges arising from shifts toward cardioselective agents with better safety profiles, and patent expirations enabling generics, affect its market dynamics.
Raw Material for Oxprenolol Production
According to the oxprenolol production plant project report, the key raw materials used in the production of oxprenolol include 2-(allyloxy)phenol and epichlorohydrin.
Production Process of Oxprenolol
The extensive oxprenolol production cost report consists of the following major industrial production process:
- From 2-(allyloxy)phenol: The production process of oxprenolol involves several steps. First, 2-(allyloxy)phenol reacts with epichlorohydrin under basic conditions to form a glycidyl ether epoxide intermediate. This intermediate then opens via nucleophilic attack with isopropylamine to yield the free base oxprenolol. After that, the treatment with hydrochloric acid in a suitable solvent like isopropanol or ethanol forms the stable hydrochloride salt. Finally, purification via recrystallization to give oxprenolol hydrochloride as the final product.
Oxprenolol has the molecular formula of C15H23NO3 and a molecular weight of 265.35 g/mol (free base). It appears as a white to off-white solid with a melting point of 78-80 °C. Its hydrochloride salt form has a molecular weight of 301.81 g/mol and shows better solubility in solvents like DMF, DMSO, ethanol, and PBS. The base shows slight solubility in dichloromethane and methanol. It shows a log P of 2.10 that makes it moderately lipophilic. It has a density of around 1.05 g/cm³ with a refractive index of around1.50. It has a boiling point of 409 °C, and a pKa value of 13.89±0.20. It features a chiral centre and is used as a racemic mixture of (R)-(+)- and (S)-(-)-enantiomers and is stable under recommended storage at -20 °C.